Venture Capital

A new drug, JIN-A02, shows early promise in overcoming resistance to common lung cancer therapies, even shrinking hard-to-treat brain metastases.

A potential first therapy for Charcot-Marie-Tooth disease heads to a major conference, showing promising functional gains despite missing its primary goal.

The National Business League returns to its roots, establishing a high-tech economic hub in Alabama to empower Black enterprises globally.

With 6,000+ attendees, INTA's London meeting will tackle AI inventorship, global brand protection, and the future of innovation. Here's what's at stake.

Dating apps are out, and home cooking is in. A new campaign from Knorr taps into Gen Z's search for authenticity, turning kitchens into the new frontier for romance.

Indoor ag firm Local Bounti faces a potential NYSE delisting for the second time, highlighting severe financial pressures in the high-tech farming sector.

Gloo's major sponsorship of NRB 2026 signals a new era of AI in faith, but raises critical questions about technology's role in modern spirituality.

As AI reshapes financial communications, 5W PR launches a new division to help investment firms build trust and cut through the digital noise.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

A new abrasive-free technology from ChEmpower promises to eliminate critical defects, boosting yield and performance for next-generation AI and HBM chips.

A non-invasive device for spinal cord injury gains major international praise, signaling a shift in neurorehabilitation and a path to market.

The low-cost giant is shaking up long-haul travel with a new Kuala Lumpur-Bahrain-London route, establishing a strategic hub outside of Asia.

Tenna's hardware-free platform maps radio interference in real-time, securing a $13.5M investment to protect critical defense and aerospace assets.

New patents protect Electra's radical blown-lift tech, paving a practical FAA certification path for its EL9 aircraft and challenging the eVTOL model.

Backed by Bessemer & GV, the startup led by Twilio's ex-CEO will commercialize the only fusion approach with proven net energy gain.

Bio-Techne promotes Steve Crouse to lead its high-growth Diagnostics and Spatial Biology unit, signaling a strategic focus on innovation after a key divestiture.

A new partnership will deploy modular AI factories in Texas, aiming to solve the industry's critical power and speed bottlenecks with an innovative approach.

Wesley Pharmaceuticals launches a 503B-compliant NAD+ injection, promising quality in the booming anti-aging market amid scientific debate over its efficacy.

QuickLogic will showcase an eFPGA chiplet on Intel's 18A process at Chiplet Summit 2026, signaling a new era of flexible, post-silicon hardware design.

Katherine Stueland’s honor underscores a major shift in healthcare, as genomic screening and AI promise to end the diagnostic odyssey for rare diseases.